search
Back to results

Proximal Resistance Training for People With Multiple Sclerosis (PT-MS)

Primary Purpose

Multiple Sclerosis

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Proximal Resistance Training
Sponsored by
University of Colorado, Denver
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Multiple Sclerosis focused on measuring Exercise, Hip abduction, Trunk muscles

Eligibility Criteria

18 Years - 64 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria.

  • 18-64 years old
  • Neurologist-confirmed diagnosis of MS
  • Able to walk at least 100 meters without an assistive device
  • Expanded Disability Status Scale - EDSS < 6
  • Have their own tablet/phone/computer capable of video calls/Zoom meetings.

Exclusion Criteria.

  • Other conditions limiting their ability to exercise or walk
  • Unsafe to exercise as determined by a neurologist or physical therapist
  • Currently undergoing physical therapy
  • Unable to provide consent or follow simple directions
  • Have an MS-related exacerbation or changes to their disease-modifying drug therapy in the month prior to enrollment
  • A 25 foot walk test time of > 4.5 seconds

Sites / Locations

  • University of Colorado

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Proximal Resistance Training

Arm Description

Participants will receive 6 one-on-one supervised intervention visits and 8 telerehabilitation visits over 10 weeks. For the first 4 weeks intervention frequency will start with 1x/ week in clinic and 1x/ week via telerehabilitation, and the participant will be asked to perform exercises 2x/ week independently. For the final 6 weeks there will be 1x week supervised visits (weeks 6 and 8 in person, and weeks 5,7, 9, and 10 via telerehabilitation) and the participant will be asked to perform exercises 3x/ week independently.

Outcomes

Primary Outcome Measures

Change in 6-minute walk test
The 6MWT assesses walking endurance via the maximal distance an individual is able to walk in 6 minutes, reported in meters

Secondary Outcome Measures

Change in average daily step count
Step count will be measured by waist-mounted ActiGraph accelerometer-based activity monitors
Change in movement patterns
Mechanisms of movement patterns will be measured by 3-dimensional motion capture analysis during self-selected walking speed and during a 30 second chair raise test.
Change in Multiple Sclerosis Walking Scale-12
A 12 questions assessment of self-reported walking mobility in people with multiple sclerosis. Scores range from 0 to 100 with higher scores indicating better mobility.
Change in Multiple Sclerosis Self-Efficacy Score
An 18 item assessment of measures of self-efficacy in multiple sclerosis including a function component and a control component. Total score is reported on a 10-100 point scale with higher scores indicating greater certainty in ones ability to manage multiple sclerosis symptoms.
Change in Exercise Self-Efficacy Scale
A 9 item questionnaire that assesses perceptions about ability to participate in at least 20 minutes of moderate physical activity 3x per week. Scores range from 0 to 90 points with higher scores indicating more confidence to exercise in different circumstances.
Change in Exercise Stages of Change category
A 4 item measure to assess readiness to participate in exercise and activity. Depending on the answers to the yes/no questions, results are categorized as "pre-contemplation", "contemplation", "preparation", "action", and "maintenance".
Change in Modified Fatigue Impact Scale
The standard measure of patient-reported limitations due to fatigue in people with MS. Scores range from 0 to 84 with higher scores indicating higher impact of fatigue on daily activities.

Full Information

First Posted
September 8, 2020
Last Updated
May 11, 2023
Sponsor
University of Colorado, Denver
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
search

1. Study Identification

Unique Protocol Identification Number
NCT04548154
Brief Title
Proximal Resistance Training for People With Multiple Sclerosis
Acronym
PT-MS
Official Title
Proximal Resistance Training to Improve Walking Capacity and Physical Activity in People With Multiple Sclerosis: A Feasibility Study
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
October 12, 2020 (Actual)
Primary Completion Date
June 30, 2023 (Anticipated)
Study Completion Date
June 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Colorado, Denver
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The objective of this study is to pilot a 10-week resistance and functional movement intervention targeting proximal muscles in 40 people with MS. The investigators will assess implementation feasibility (recruitment, fidelity, retention, satisfaction), collect pilot data for key walking function outcomes, and examine movement-pattern and activity behavior mechanisms. Walking function will be measured by walking capacity (6-Minute Walk Test - 6MWT) and PA quantity (average steps/ day over 10 days). Movement-pattern mechanisms will be measured using 3D motion capture analysis (pelvis and trunk kinematics). Activity behavior mechanisms will be measured by patient-reported outcome questionnaires (perception of walking ability, self-efficacy, and readiness to change).
Detailed Description
The proposed study will be a prospective cohort in 40 people with MS with one baseline and one follow-up assessment after a 10-week functional resistance training intervention. The screening and outcome assessments will take place in the CU Interdisciplinary Movement Science Lab and intervention will occur in the CU Physical Therapy Program gym. Both facilities have the necessary space and equipment for outcomes assessment and intervention, respectively. The PI will perform the initial screening and deliver the intervention. In order to limit testing bias, all functional tests, patient-reported outcomes, and motion capture data collection will be performed by an experienced research assistant. Participants will receive 14 one-on-one supervised intervention visits over 10 weeks. Intervention frequency will mimic clinical practice, starting at 2x/ week in clinic (2x/ week independently) for four weeks and tapering to 1x/ week in clinic (3x/ week independently) for the final six weeks. Participants will be prescribed 5 categories of resistance exercises, and each category will have a series of exercises to select from. Two will target hip abduction (lying down and standing), two will target trunk muscles (sidelying/ forward planks, resisted trunk rotation), and one will target functional resistance training for the hip and trunk during walking-related tasks such as multi-directional resisted walking. Dosing will be based on guidelines for MS. Strengthening exercises will begin with 3 sets of 12-15 reps at 15 rep-max load (RM) and progress to 3 sets of 8-10 reps at 10-12 RM. Endurance exercises requiring a static hold will progress from 3 sets of 15-20 second holds to 30-second holds. Functional resistance will be dosed to improve muscular endurance: 3 sets of 15-20 reps based on form fatigue. Progression will be achieved by modifying body position, and/or adding cuff weights or resistance bands. Exercises will take 30-45 minutes to complete. Upper extremity use to maintain balance will be allowed as needed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis
Keywords
Exercise, Hip abduction, Trunk muscles

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
34 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Proximal Resistance Training
Arm Type
Experimental
Arm Description
Participants will receive 6 one-on-one supervised intervention visits and 8 telerehabilitation visits over 10 weeks. For the first 4 weeks intervention frequency will start with 1x/ week in clinic and 1x/ week via telerehabilitation, and the participant will be asked to perform exercises 2x/ week independently. For the final 6 weeks there will be 1x week supervised visits (weeks 6 and 8 in person, and weeks 5,7, 9, and 10 via telerehabilitation) and the participant will be asked to perform exercises 3x/ week independently.
Intervention Type
Other
Intervention Name(s)
Proximal Resistance Training
Intervention Description
Participants will be prescribed 5 categories of resistance exercises, and each category will have a series of exercises to select from. Two will target hip abduction, two will target trunk muscles, and one will target functional resistance training for the hip and trunk during walking-related tasks such as multi-directional resisted walking. Dosing will be based on guidelines for MS. Strengthening exercises will begin with 3 sets of 12-15 reps at 15 rep-max load (RM) and progress to 3 sets of 8-10 reps at 10-12 RM. Endurance exercises requiring a static hold will progress from 3 sets of 15-20 second holds to 30-second holds. Functional resistance will be dosed to improve muscular endurance: 3 sets of 15-20 reps based on form fatigue.
Primary Outcome Measure Information:
Title
Change in 6-minute walk test
Description
The 6MWT assesses walking endurance via the maximal distance an individual is able to walk in 6 minutes, reported in meters
Time Frame
Baseline, end of 10 week intervention period, 22 week follow-up.
Secondary Outcome Measure Information:
Title
Change in average daily step count
Description
Step count will be measured by waist-mounted ActiGraph accelerometer-based activity monitors
Time Frame
Baseline, end of 10 week intervention period, 22 week follow-up.
Title
Change in movement patterns
Description
Mechanisms of movement patterns will be measured by 3-dimensional motion capture analysis during self-selected walking speed and during a 30 second chair raise test.
Time Frame
Baseline, end of 10 week intervention period, 22 week follow-up.
Title
Change in Multiple Sclerosis Walking Scale-12
Description
A 12 questions assessment of self-reported walking mobility in people with multiple sclerosis. Scores range from 0 to 100 with higher scores indicating better mobility.
Time Frame
Baseline, end of 10 week intervention period, 22 week follow-up.
Title
Change in Multiple Sclerosis Self-Efficacy Score
Description
An 18 item assessment of measures of self-efficacy in multiple sclerosis including a function component and a control component. Total score is reported on a 10-100 point scale with higher scores indicating greater certainty in ones ability to manage multiple sclerosis symptoms.
Time Frame
Baseline, end of 10 week intervention period, 22 week follow-up.
Title
Change in Exercise Self-Efficacy Scale
Description
A 9 item questionnaire that assesses perceptions about ability to participate in at least 20 minutes of moderate physical activity 3x per week. Scores range from 0 to 90 points with higher scores indicating more confidence to exercise in different circumstances.
Time Frame
Baseline, end of 10 week intervention period, 22 week follow-up.
Title
Change in Exercise Stages of Change category
Description
A 4 item measure to assess readiness to participate in exercise and activity. Depending on the answers to the yes/no questions, results are categorized as "pre-contemplation", "contemplation", "preparation", "action", and "maintenance".
Time Frame
Baseline, end of 10 week intervention period, 22 week follow-up.
Title
Change in Modified Fatigue Impact Scale
Description
The standard measure of patient-reported limitations due to fatigue in people with MS. Scores range from 0 to 84 with higher scores indicating higher impact of fatigue on daily activities.
Time Frame
Baseline, end of 10 week intervention period, 22 week follow-up.
Other Pre-specified Outcome Measures:
Title
Change in Patient-Specific Functional Scale
Description
Participant identifies 3 activities that the participant is unable to do, or is difficult for the participant to do and rates them on a 10-point scale, with higher scores indicating greater ability to perform activity.
Time Frame
Baseline and end of 10 week intervention period.
Title
Change in hip abduction strength
Description
Hip abduction strength will be measured in kg using hand-held dynamometry.
Time Frame
Baseline, end of 10 week intervention period, 22 week follow-up.
Title
Change in lateral trunk flexion strength
Description
Lateral trunk flexion strength will be measured in kg using hand-held dynamometry.
Time Frame
Baseline, end of 10 week intervention period, 22 week follow-up.
Title
Change in lateral trunk flexion endurance
Description
Trunk flexion endurance as measured by a clinical trunk curl-up test which counts the number of trunk curls a participant can perform in 1 minute.
Time Frame
Baseline, end of 10 week intervention period, 22 week follow-up.
Title
Expanding Disability Status Scale
Description
Neurological exam used to assess disability in people with multiple sclerosis. Scores range from 0 to 6 with higher scores indicating more disability.
Time Frame
Baseline
Title
25 Foot Walk Test
Description
Amount of time in seconds it takes for participant to walk 25 feet as quickly and safely as possible.
Time Frame
Baseline and after the 10 week intervention period.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria. 18-64 years old Neurologist-confirmed diagnosis of MS Able to walk at least 100 meters without an assistive device Expanded Disability Status Scale - EDSS < 6 Have their own tablet/phone/computer capable of video calls/Zoom meetings. Exclusion Criteria. Other conditions limiting their ability to exercise or walk Unsafe to exercise as determined by a neurologist or physical therapist Currently undergoing physical therapy Unable to provide consent or follow simple directions Have an MS-related exacerbation or changes to their disease-modifying drug therapy in the month prior to enrollment A 25 foot walk test time of > 4.5 seconds
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mark M. Manago, DPT, PhD
Organizational Affiliation
University of Colorado, Denver
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Colorado
City
Aurora
State/Province
Colorado
ZIP/Postal Code
80045
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
We will publish the trial results data on the ClinicalTrials.gov website, on which the clinical trial will be registered. Sharing of data will include the potential of sharing raw data generated from all clinical assessments under a data-sharing agreement.
IPD Sharing Time Frame
We will publish the trial results within one year of testing the final participant.
IPD Sharing Access Criteria
User registration will be required to access/download any data and will require agreement to conditions of use in accordance with NIH Data Sharing Policy Guidelines.

Learn more about this trial

Proximal Resistance Training for People With Multiple Sclerosis

We'll reach out to this number within 24 hrs